Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Cantor Fitzgerald
Argus Health
UBS
Colorcon
US Army
Merck
Deloitte
Dow
Baxter

Generated: January 17, 2018

DrugPatentWatch Database Preview

Aspirin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for aspirin and what is the scope of aspirin freedom to operate?

Aspirin
is the generic ingredient in fifty-three branded drugs marketed by New Haven Pharms, Plx Pharma, Bayer, Savage Labs, Nostrum Labs Inc, Watson Labs, Allergan Sales Llc, Lannett, Actavis Elizabeth, Halsey, Hikma Intl Pharms, Ivax Pharms, PII, Puracap Pharm, Quantum Pharmics, Sandoz, Mayne Pharma Inc, Nexgen Pharma Inc, Stevens J, Vintage Pharms Llc, Sun Pharm Industries, Medicis, Prinston Inc, Alra, Xanodyne Pharm, Ivax Sub Teva Pharms, Teva, Heritage Pharms Inc, Novast Labs Ltd, Oxford Pharms, Meda Pharms, Ingenus Pharms Nj, Boehringer Ingelheim, Amneal Pharms, Barr, Impax Labs Inc, Par Pharm Inc, Sandoz Inc, Zydus Pharms Usa Inc, Schwarz Pharma, Abbott, Par Pharm, Medpointe Pharm Hlc, Mcneil, Robins Ah, Aralez Pharms, Actavis Labs Fl Inc, Endo Pharms, Roxane, Sanofi Aventis Us, Bristol Myers Squibb, and Aaipharma Llc, and is included in eighty-one NDAs. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Aspirin has thirty-two patent family members in eighteen countries.

There are twenty-one drug master file entries for aspirin. One supplier is listed for this compound.

US Patents and Regulatory Information for aspirin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms METHOCARBAMOL AND ASPIRIN aspirin; methocarbamol TABLET;ORAL 087211-001 Dec 22, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Xanodyne Pharm DARVON COMPOUND aspirin; caffeine; propoxyphene hydrochloride CAPSULE;ORAL 010996-006 Mar 8, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva PROPOXYPHENE COMPOUND 65 aspirin; caffeine; propoxyphene hydrochloride CAPSULE;ORAL 089025-001 Mar 29, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mcneil METHOCARBAMOL AND ASPIRIN aspirin; methocarbamol TABLET;ORAL 089193-001 Feb 12, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Nostrum Labs Inc BUTALBITAL, ASPIRIN AND CAFFEINE aspirin; butalbital; caffeine CAPSULE;ORAL 078149-001 Jun 13, 2007 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Meda Pharms SOMA COMPOUND aspirin; carisoprodol TABLET;ORAL 012365-005 Jul 11, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schwarz Pharma AZDONE aspirin; hydrocodone bitartrate TABLET;ORAL 089420-001 Jan 25, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Meda Pharms SOMA COMPOUND W/ CODEINE aspirin; carisoprodol; codeine phosphate TABLET;ORAL 012366-002 Jul 11, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Pharm METHOCARBAMOL AND ASPIRIN aspirin; methocarbamol TABLET;ORAL 089657-001 Nov 4, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pii BUTALBITAL, ASPIRIN AND CAFFEINE aspirin; butalbital; caffeine TABLET;ORAL 204195-001 Sep 22, 2016 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for aspirin

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,730,884 pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same ➤ Subscribe
8,911,752 Methods of making compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity ➤ Subscribe
9,687,551 Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for aspirin

Supplementary Protection Certificates for aspirin

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
12/048 Ireland ➤ Subscribe PRODUCT NAME: A COMBINATION PRODUCT COMPRISING ASPIRIN AND ESOMEPRAZOLE MAGNESIUM TRIHYDRATE; NAT REGISTRATION NO/DATE: PA 970/063/001 20120831; FIRST REGISTRATION NO/DATE: 5402359; 5402367 5402375 20110812
2012000017 Germany ➤ Subscribe PRODUCT NAME: ASPIRIN UND ESOMEPRAZOL - MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 81047.00.00 20110930 FIRST REGISTRATION: PORTUGAL 5402359 5402367 5402375 20110812
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Cantor Fitzgerald
Colorcon
Boehringer Ingelheim
Federal Trade Commission
Harvard Business School
QuintilesIMS
Medtronic
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot